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Abstract
Manganese uptake by human erythrocytes was investigated in the concentration range 0.5–20 mM in the suspending
solution, by using the EPR technique. S shaped dependencies of manganese influx on manganese doping solution
concentration for both fresh and vanadate treated erythrocytes were found, with maximum influx values of 4.1"1.9=10y10
2 y9 2  .molrm =s and 2.1"0.3=10 molrm =s, respectively. At low manganese concentrations -2 mM the manganese
permeability coefficient increases with increasing the doping concentration, the ions cooperate for achieving a transport
 .event. For high manganese concentration )5 mM the permeability coefficient decreases with increasing the doping
concentration, the ions competing for the limited amount of transport system. A similar increase in manganese uptake as in
vanadate treated erythrocytes was measured for ‘in vitro’ aged erythrocytes. These results might suggest that human
erythrocytes possess an active transport mechanism by which, they oppose to manganese influx. This hypothesis is also
supported by the 10–15 min time lag between the moment of doping and the start of the manganese influx into the fresh
erythrocytes. The manganese uptake inhibition by nifedipine, a calcium channel blocker, for the case of vanadate treated
erythrocytes, suggests that, at least partially, manganese uptake by the cells occurs via the ‘calcium channels’. q 1997
Elsevier Science B.V.
Keywords: Manganese; Erythrocyte; EPR
1. Introduction
The manganese permeability of the human red
blood cell membranes was measured in the early 60’s
w xby using a radioisotopic method 1 . It was found that
manganese enters the cells via a passive diffusion
mechanism, with a permeability coefficient of 2.87=
) Corresponding author. Institute of Isotopic and Molecular
Technology, P.O.Box 700, 3400 Cluj-Napoca, Romania. Fax:
q40 64 420042.
10y11 mrs. Due to the apparent chemical instability
of their radiomanganese stock solutions, the authors
of this study limited the divalent cation concentration
to up to 0.5 mM and excluded molecular oxygen
from the system.
The interest for the manganese divalent ion in-
creased when it was suggested that it could be conve-
niently used as a calcium probe, as it is now well
established that in many species and cellular systems
it is transported through the cell membranes via the
calcium transport pathways. Manganese is taken up
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w xby mitochondria over the calcium uniporter 2 and
w xpenetrates into rat ileal cells 3 , rat peritoneal mast
w x w xcells 4 , bovine chromaffin cells 5 , insect muscle
w x w xmembranes 6 , mouse ovarian oocyte 7 , myoepithe-
w xlial cells of a spongi 8 , sarcolemma of the rat heart
w x9 , sarcoplasmic reticulum of rabbit skeletal muscle
w x w x w x10 , human platelets 11 , rat hepatocytes 12 via the
calcium channels. Rat astrocytes transport manganese
via a specific transport system, which is not inhibited
 2q 2q 2q.by other divalent cations Co , Zn , Pb and it
is reduced only in the presence of 2–3 order of
2q w xmagnitude higher Ca concentrations 13 . On the
other hand it was demonstrated that passive calcium
uptake by the human erythrocytes is mediated to a
large extent by a ‘Ca2q channel’ being inhibited by
calcium channel antagonists and divalent cations such
2q 2q 2q 2qw xas Zn , Cu , Co and Cd 14 .
Due to its paramagnetic properties, Mn2q was
extensively used as a paramagnetic probe in NMR
w xexperiments. Conlon and Outhred 15 have proposed
a NMR technique, now frequently used, for measur-
ing the water exchange times through the erythrocyte
membranes by using up to 40 mM manganese as a
magnetic label of the external cell environment. A
prerequisite of the method is that the added man-
ganese ions do not penetrate through the cell mem-
branes. However, as it was demonstrated in our labo-
w xratory 16,17 , this condition holds true only for the
first 10–15 min of the experiment, in whole blood or
in samples doped with low manganese concentra-
tions. In washed erythrocytes andror at high man-
ganese doping concentrations the NMR data can be
strongly influenced by the paramagnetic ions perme-
w xation through the cell membranes 18 .
On the other hand, it was demonstrated that the
water exchange times through the human erythrocyte
membranes, measured by using the NMR manganese
doping technique are modified in cells from patients
w xwith various pathologies 19,20 . These results could
be interpreted also as changes in the manganese
permeability of the cells in certain pathologies.
For all these reasons it was felt that a systematic
investigation of the manganese transport into human
erythrocytes in a broad range of manganese concen-
trations and in the presence of known inhibitors was
necessary.
In this paper we used an electron paramagnetic
 .resonance EPR method for measuring the man-
ganese uptake by the human red blood cells. The
EPR technique is very sensitive to changes in the
paramagnetic cation binding andror changes in the
w xoxidation state 21 and it was also applied for mea-
w xsuring manganese uptake by mitochondria 22 . Our
method is based on the fact that manganese doped
hemolysates do not exhibit detectable EPR signals.
As a consequence, the EPR signal of a manganese
doped suspension of red blood cells is related to the
outer cell paramagnetic ions. A decay in the EPR
signal amplitude is therefore explained by the cation
penetration into the cells and subsequent binding. We
measured the manganese uptake by fresh, ‘in vitro’
aged and vanadate treated erythrocytes, as well as the
effects of temperature and of Ca2q entry blockers on
manganese uptake for a large range of manganese
 .doping concentrations 0.5–20 mM . We performed
measurements at these high concentrations mainly for
 .two reasons: i these are the usual concentrations
used in NMR experiments for measuring the water
 .permeability of red blood cells and ii we presup-
posed that manganese enters the cells via the calcium
transport pathways, which saturate at concentrations
above 5 mM.
A preliminary abstract of a part of this work has
been published Copaescu, L.I., Dragu, C. and Lu-˘
 .caciu, C.M. 1996 Progr. Biophys. Mol. Biol. 65
.Suppl. I, 100. .
2. Materials and methods
2.1. Materials
N-2-Hydroxyethylpiperazine-N X-2-ethanesulfonic
 .acid HEPES was from Sigma Chemicals Co., man-
 .ganese II chloride, ethylenediamine tetraacetic acid
 .EDTA and sodium vanadate were from Merck and
nifedipine from Terapia, Ltd. All solutions were made
in doubly distilled water. All other chemicals were of
analytical grade.
2.2. Blood preparation
Human blood obtained by venipuncture from ap-
parently healthy donors was collected on either EDTA
or heparin and used within 2 h. Whole blood was
 .centrifuged Janetzki T-24 for 10 min at 1000=g.
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After centrifugation plasma and buffy coat were care-
fully removed by aspiration. Subsequently the red
blood cell pellet was washed three times in an iso-
tonic solution buffered at pH 7.4 145 mM NaCl; 5
.mM KCl, 5 mM HEPES . The final centrifugation
lasted 10 min, the supernatant and the top 0.5 ml red
blood cell being removed by aspiration.
The samples for EPR were prepared prior to the
measurement by thoroughly mixing an aliquot of
washed erythrocytes with an appropriate volume of
isotonic doping solution containing variable amounts
of manganese chloride, buffered at pH 7.4.
In parallel, 0.5 ml of the doped suspension were
centrifuged in hematocrit tubes at 2000=g for 30
min. The ratio between the cell pellet volume and the
whole suspension volume, corrected for the trapped
water, was used as the probe hematocrit in the subse-
quent calculations.
w xVarecka and Carafoli 23 have shown that prein-
cubation of human red blood cells with 0.5 mM
vanadate, leads to the inhibition of the red blood cell
active transport system after permeation of the mem-
brane through the anion exchange system. They used
this method to study Ca2q passive influx into the red
blood cell.
w xEngelmann and Duhm 14 have shown that vana-
date reaches its maximum effect at or above 2 mM.
We incubated the erythrocytes at 378C for 30 min in
HEPES buffered saline supplemented with 2 mM
vanadate, i.e. with arrested active transport systems.
After this treatment the cells were washed again and
we measured the manganese influx for various man-
ganese concentrations.
Nifedipine was dissolved in absolute ethanol and
this solution was added to the doping solution. In
preliminary experiments it was checked that 2%
ethanol in the suspending medium does not change
significantly manganese transport through the red
blood cell membranes. The experiments with nifedip-
ine were carried out in the dark.
2.3. EPR measurements
The doped suspension of cells was aspirated in a
glass capillary tube and mounted in the resonance
chamber of an X-band EPR spectrometer ART-6,
.IFIN Bucharest . The spectrometer resonance cham-
ber was thermostated at 37"18C by using air flow.
The spectrometer settings were: microwave fre-
quency 9.01 GHz, modulation frequency 100 kHz,
modulation field 2 Gs.
The EPR spectra were continuously recorded. The
data were analyzed by simply measuring the ampli-
tudes of the first derivative six lines Mn2q spectra,
furnished by the spectrometer. We previously checked
that, up to 100 mM MnCl in HEPES buffered2
saline, the amplitude of the divalent manganese EPR
spectrum increases linearly with the manganese chlo-
ride concentration coefficient of determination better
.than 0.99 .
2.4. Manganese binding to cell hemolysate
In preliminary experiments for the titration of
manganese binding to intracellular compounds,
washed erythrocytes were frozen in liquid nitrogen
and then thawed at 378C. This cycle was repeated
three times. After 30 min of centrifugation at 2500=g
the hemolysate was diluted 5 times in double distilled
water. No membrane fragments were seen under
these conditions in the supernatants by using dark
field microscopy. Equal volumes of hemolysate solu-
 .tions were mixed with manganese II chloride stock
solutions and HEPES buffered at pH 6.9. The EPR
technique was used to measure the divalent man-
ganese binding to intracellular compounds. Measure-
ments were made in the same glass capillary tube,
mounted always in the same position in the spectrom-
eter resonance chamber. The divalent manganese EPR
signals for doped hemolysates were compared with
those of manganese chloride standards measured in
the same conditions. The hemolysate concentration
was expressed in units of hemoglobin concentration,
the major cytoplasm protein, which was measured by
using the cianmethemoglobin method.
Due to their restricted rotational molecular motion,
paramagnetic ions bound to macromolecules present
a strong increase, beyond the detection limit, in the
w xwidth of the EPR signals 21 . Thus for manganese
chloride doped hemolysates, only the free manganese
ions will contribute to the observable EPR signal.
From the difference between the total manganese
concentration, known from the preparation, and the
EPR measured free divalent ion concentration, we
obtained the bound manganese concentration.
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We analyzed the data by using the Scatchard Klotz
equation:
1rmsK r nMn q1rn 1 .D f
were m is the average number of metal ions bound
per molecule of protein, n is the number of metal
binding sites assumed to be equivalent and indepen-
. w xdent , K is the dissociation constant and Mn isD f
the free manganese ion concentration. From the plot
w x1rm versus 1r Mn , which was linear, we obtainedf
a dissociation constant of K s3.36"0.43 mM andD
a number of binding sites ns16.2"1.3. These re-
sults emphasize the large binding capacity of the red
blood cell inner components.
w xRiddell and Zhou 24 have not observed any
change with time in the width of the intracellular
35Cly NMR line in human erythrocytes, in the pres-
ence of extracellular Mn2q. As the NMR line broad-
ening of 35Cly is very sensitive to the addition of
small concentrations of Mn2q this result is a very
strong evidence for extremely tight binding of intra-
cellular Mn2q supporting our findings.
At this moment it is not clear the ligand to which
manganese binds when added to hemolysates, but is
presumable that several molecules can contribute to
w xthis effect. It was demonstrated 1 that 60% of the
manganese taken up by the red blood cells or added
to hemolysates are not ultrafilterable and no satura-
tion of the manganese binding sites was observed for
concentrations ranging from 10y7 M to 10y3 M.
w xGupta and Benovic 25 have found, by using the
EPR technique, that 2,3-bisphosphoglycerate binds
manganese ions with a dissociation constant K sD
0.75 mM, having two binding sites. Other red blood
cell molecules which bind tightly manganese are
 . w xATP, ADP K ;0.1 mM 25 . We expressed theD
hemolysate concentration in units of hemoglobin
which has a molecular mass of several orders of
magnitude higher than other potential manganese lig-
ands. Therefore our value for the dissociation con-
stant is only a mean, which is seen for all these
molecule types, but having a practical use in estimat-
ing the fraction of free metal ions when added to cell
hemolysates.
With these values for K and n we have calcu-D
lated that, at the highest manganese concentration
 .used in this study i.e. ;20 mM , at equilibrium, for
a 50% hematocrit suspension, the free manganese
concentration inside the cell will contribute with less
than 5% to the overall EPR signal. Therefore, for all
practical reasons, the inner cell manganese can be
considered bound to intracellular compounds. The
detected EPR signals of manganese doped suspen-
sions of red blood cells were attributed to the outer
cell divalent manganese ions.
w xWeed and Rothstein 1 have reported a fast man-
ganese association with the red blood cells, which
they attributed to the cation binding to the cell mem-
branes. They found that about 5% from the doping,
which was less than 0.5 mM, was associated with the
cells in red cell suspensions or with red cell isolated
w xmembranes. Getz et al. 26 have measured the EPR
signals of 5 mM manganese doped suspensions of
erythrocytes and they did not observed changes in the
Mn2q EPR signal amplitude or shape. They con-
cluded that manganese ions do not bind to red blood
cell membranes. In the conditions used in our study
relatively high manganese concentrations, about 50%
.hematocrit the binding of a small amount of man-
ganese to red blood cell membranes is masked by the
decrease in the manganese concentration caused by
the dilution due to the water trapped between the
cells.
At high manganese concentrations and for long
incubation times hemolysis occurs and this phe-
nomenon can influence the concentration of the free
manganese ions and subsequently the divalent man-
ganese EPR signal amplitude, leading to artefactual
permeability data. We reduced the incubation times
 .usually we used 30 min to reduce the influence of
 .hemolysis which was less than 1% on the perme-
ability data.
w xWeed and Rothstein 1 have measured a day to
day change in the manganese uptake by the red blood
cells, which they attributed to the oxidation of the
radiomanganese stock solutions. However, polaro-
graphic determinations revealed only small changes
in the Mn2q concentrations of their stock solutions,
which could not account for the significant day to
day changes in the manganese uptake by the cells.
High hemolysis rates and possible divalent man-
ganese oxidation andror precipitation when incubat-
 .  .ing cells for long times )3 h at high )5 mM
w xmanganese concentrations were also reported 1 .
As the EPR method is very sensitive to changes in
the state of the paramagnetic ions, Mn2q oxidation,
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precipitation or binding can be very easily monitored
by using this technique. We did not measured signifi-
cant changes in the EPR divalent manganese signal
amplitude of our MnCl stock solution during several2
days. No such types of difficulties were reported by
an other group of investigators who measured the
Mn2q EPR signal of manganese doped suspension of
w xerythrocytes 26 .
Using two different techniques, EPR and atomic
 .absorption spectroscopy AAS we have demon-
strated that the decrease in the manganese concentra-
tion of the manganese doped erythrocyte supernatants
parallels the decrease observed in the Mn2q EPR
signal, at least for the first 30 min of incubation
Lucaciu C.M., Bindea C. and Morariu V.V., unpub-
.lished data . For longer incubation periods hemolysis
can affect the EPR data, leading to artefactual higher
permeability coefficients. However, as in AAS both
Mn2q and Mn3 q are detected and the EPR tech-
nique detects only Mn2q, we concluded that no sig-
nificant oxidation of the divalent manganese occurs
in the conditions used in our experiments.
2.5. Data analysis
The data were interpreted in terms of a two com-
partment model, intra and extracellular, considering
that only the diffusion through the membrane is the
rate limiting factor. Having in mind that inside the
cells, the manganese ions are bound and nondiffus-
able, we obtained, after a straightforward integration,
the time dependence of the number of extracellular
manganese ions:
NsN =exp yk= t 2 .  .o
or
NsN =exp yP=H=S= trV= 1yH 3 .  .o
where N is the initial number of manganese ions, k
is the kinetic coefficient, P is the permeability coef-
ficient, H the suspension hematocrit and S and V are
the normal erythrocyte surface area and volume, re-
spectively.
Since the inner cell manganese ions are bound and
nondiffusable, we have considered that the volume in
which the ions diffuse is infinity. Under these cir-
cumstances the equation shows that for very long
incubation times the extracellular manganese ion con-
centration tends to zero, i.e. the divalent cations
accumulate into the cells.
The manganese ions influx into the cells was
calculated as the product between the permeability
coefficient and the manganese doping solution con-
centration.
3. Results
Following the EPR signal of the divalent man-
ganese ion added to a suspension of human erythro-
cytes we observed a gradual decrease in the six lines
signal amplitudes. As it was discussed above, this
decrease is related to manganese uptake by the red
blood cells and subsequent binding to inner cell
components. No significant changes in the shape of
the Mn2q six lines spectra were detected. However,
for very long incubation times, after a drastically
decrease in the signal amplitude, the modulation of
2q the six lines Mn spectrum with a large line ;300
.Gauss was observed. It seems that, in these cases,
there is a superposition of the isolated extracellular
Mn2q aqueous ions signal with a signal arising from
a small fraction of strongly dipole-dipole interacting
Mn2q ions. This fact may indicate that, inside the
erythrocytes, there are small pools with free man-
ganese ions, having a high local concentration.
Some typical recordings are given in Fig. 1. In
certain cases the decrease in the Mn2q occurs only
Fig. 1. Time dependence of the Mn2q EPR signal amplitude
added to red blood cell suspensions from the same washed red
blood cell pellet doped successively at 1 hour time intervals in
the order: B, v, ’, %. Manganese doping concentration was 5
mM for each sample.
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after 10–15 min of incubation. This observation sug-
gests that the cells possess a mechanism by which, in
certain conditions, they oppose to the manganese
influx, for a short time at the beginning of the influx
experiment. This phenomenon did not occurred in
every sample. We could not made a clear cut correla-
tion for this type of behavior with the preparation
procedure steps, or with the doping manganese con-
centration.
For samples, from the same washed red blood cell
pellet, doped successively at 1 h time intervals, we
obtained influx curves having similar slopes, but with
significant differences in the first part of the influx
 .experiment Fig. 1 . The cell pellet was kept at room
temperature until doping each sample. While for the
first sample the decrease in the Mn2q EPR signal
occurs only after about 10–15 min of incubation, for
the subsequent dopings this time interval is reduced.
For the last sample no such a behavior can be
detected. For these reasons, care was take to measure
the manganese influx within a short time interval
after the blood was collected.
We obtained large differences between the perme-
ability coefficients for blood samples from different
 .donors up to 2–3 fold . For samples from the same
blood, kept at 48C, and washed successively, we
obtained for the permeability data a mean coefficient
of variation of about 10%. Within the same coeffi-
 .cient of variation 12.3%, ns4 were also the per-
meability coefficients measured for the same blood
sample in the conditions mentioned above, at differ-
 .ent hematocrit values in the range 20–60% . This
fact allows us to consider that the hematocrit correc-
 .tion in Eq. 2 was legitimate.
We found that manganese influx dependence on
manganese doping solution concentration is S shaped
 .Fig. 2 . This type of dependence is characteristic for
w xa cooperative transport mechanism 27 . The perme-
ability coefficient dependence on manganese doping
solution concentration presents a maximum at about
2 mM. For lower manganese concentration the per-
meability coefficient increases with the increase of
the manganese concentration. In this case, two or
more manganese ions cooperate to achieve transport.
At higher manganese concentration the permeability
coefficient decreases as the doping solution concen-
tration increases, competition for the limited amount
of transport system was found.
Fig. 2. Manganese influx dependence on MnCl doping solution2
 .  .concentration for B fresh erythrocytes and v vanadate treated
erythrocytes. Each point represents the mean of more than 10
samples. Bars indicate standard deviations. The dependence is S
shaped for both cases, denoting cooperativity. The solid lines are
 .the best fittings of the experimental data with Eq. 3 from which
we obtained maximum influx values of 2.1"0.3=10y9 molrm2
=s and 4.1"1.9=10y10 molrm2 =s for vanadate treated and
fresh erythrocytes, respectively.
The concentration dependence of the influx was
w xfitted with the following equation 27 :
JsC= J =CqJ r C 2 qK =CqK 4 .  . .1 2 1 2
where C is the manganese doping concentration J ,1
J , K and K are the parameters which characterize2 1 2
the transport system. We obtained for the maximum
influx at limitingly high values of C, J s4.1"1.91
=10y10 molrm2 =s and for the permeability coeffi-
 .cient at limitingly low values of C i.e. 0.5 mM
P s3.1"1.1=10y11 mrs.min
‘In vitro’ aging of the erythrocytes was obtained
by 24 h incubating the cells in their plasma, at
different temperatures. We followed the manganese
influx after washing and doping in similar conditions
as for fresh erythrocytes. The influx curves were
 .exponential and well fitted by Eq. 3 . We obtained a
gradual increase of the manganese influx, depending
on incubation temperature. For cells incubated at
378C the maximum influx was 3.4"0.4 times ns
.10 higher than the influx measured for the same
sample in 1 h after the blood was collected. This
increase may be explained either by ATP depletion or
to the various biochemical changes which occur in
w xaged cells 28 .
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The time dependence of Mn2q EPR signal ampli-
tude for manganese doped suspensions of vanadate
 .treated red blood cells are exponential Fig. 3 and
the manganese influx dependence on manganese dop-
 .ing solution concentration is S shaped Fig. 2 . Fit-
 .ting the experimental data with Eq. 3 we obtain a
maximum influx J s2.1"0.3 10y9 molrm2s,max
which is about 5 fold higher than in controls. This
strong increase in the manganese uptake by vanadate
treated erythrocytes supports the idea that the red
blood cells possess an ATP dependent mechanism, by
which they can oppose to the manganese influx.
We measured the temperature dependence of man-
ganese uptake by fresh human erythrocytes in ery-
throcyte suspensions doped with high manganese
 .concentration, near saturation 18 mM at different
temperatures. The Arrhenius plot is linear in the
 .temperature range investigated 4–378C , giving an
activation energy of 117"15 KJrmol.
Nifedipine is known as a calcium channel blocker.
For concentrations up to 0.3 mM it was found that
nifedipine decreases manganese uptake by vanadate
 .treated erythrocyte Fig. 3 . The effect depends on
nifedipine and manganese concentrations. In the pres-
ence of 0.3 mM nifedipine the manganese uptake is
Fig. 3. Time dependence of the Mn2q EPR signal added to a
 .  .suspension of red blood cells. ’ Fresh erythrocytes, v cells
pretreated by incubation 30 min at 378C in isotonic saline supple-
 .mented with 2 mM sodium vanadate, B vanadate treated
erythrocytes with 0.3 mM nifedipine in the doping solution. For
all three cases suspensions hematocrit was about 0.45 and the
erythrocytes were doped with 5 mM MnCl and incubated at2
378C in the resonance chamber of the spectrometer.
Fig. 4. Manganese influx inhibition by nifedipine. Nifedipine 0.3
.mM , dissolved in ethanol, was added in the doping medium. The
ratios between the manganese influx in the presence of nifedipine
and the manganese influx for the controls for two manganese
doping concentrations are presented. Bars indicate standard devi-
ations, ns4 for both cases.
51"11% and 66.3"21% from the controls for
manganese dopings of 5 mM and 2.5 mM, respec-
 .tively Fig. 4 .
4. Discussion
Strong evidences have been brought in previous
w xworks from our laboratory 17 for the fact that the
divalent manganese ions, added to a suspension of
human erythrocytes can penetrate through the cell
membranes, affecting the inner cell proton relaxation
times. The time decay of the water protons long
relaxation time, measured in paramagnetically doped
suspensions of cells, can be used to measure the
permeation of the paramagnetic ions through the cell
w xmembranes. Stout et al. 29 have found, by using the
NMR technique, that the divalent manganese ions
influx in Elodea leaf cells is about 3=10y10
molrm2 =s, being independent on the external man-
ganese concentration in the range 10–80 mM. How-
ever, in the case of the human erythrocytes, quantita-
tive determinations are difficult to made by using this
 .technique, mainly for two reasons: i the proton
relaxation time depends nonlinearly on the divalent
w x  .manganese concentration 30 , ii the binding of the
divalent paramagnetic cations to macromolecules
leads to a significant enhancement of the proton
w xrelaxation 21,30 . Nevertheless, qualitative evalua-
tions and comparative studies on the effect of drugs
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and pathologies on manganese uptake by human ery-
throcytes have been performed by using the NMR
w xtechnique 18,31 .
A parallel NMR and atomic absorption spectro-
 . w xscopic AAS study from our laboratory 31 has
revealed that manganese concentration into the cells
increases almost linearly in time, but starting after
10–15 min from the beginning of the experiment.
This behavior might be explained either by a cell
resistance to manganese influx at the beginning of the
experiment, or to a wrong evaluation of the very
beginning of the experiment. An other possible expla-
nation of these findings is the under evaluation of all
inner cell concentrations, due to divalent ions binding
to the cell membranes, as only the cytosolic man-
ganese was measured. It was difficult to draw clear-
cut conclusions about the first 10–15 min of influx
by using these methods, due to their low time resolu-
tion.
In the EPR method presented in this paper we
were able to monitor the manganese influx within a
few minutes from the start of the doping procedure,
followed by measurements at 1 min time interval. As
the decay in the Mn2q EPR signal amplitude occurs,
for some samples, after 10–15 min of incubation, our
EPR data clearly indicate that the cells oppose them-
selves for a while to the manganese influx.
The permeability coefficients obtained at 0.5 mM
manganese concentration, i.e. 3.1"1.1=10y11mrs
are in agreement with those obtained by Weed and
w x  y11Rothstein 1 for similar concentrations 2.87=10
.mrs . However, extending the range of the man-
ganese doping concentrations, we obtained that man-
ganese permeability increases with concentration up
to about 5 mM and then decreases. A similar behav-
ior was noticed for vanadate treated erythrocytes, in
this later case the influx values being about 5 times
higher. This type of dependence implies some coop-
erative mechanism by which the ions at low concen-
trations collaborate for achieving a transport event
w x 27 . At higher manganese concentrations above 5
.mM the permeability coefficient decreases with in-
creasing concentration. In other words the product
between the permeability coefficient and the doping
concentration tends to a constant. In terms of man-
ganese influx this means saturation.
The value of the activation energy is two times
w xhigher than that measured by Weed and Rothstein 1
 .for low manganese concentrations up to 0.5 mM .
This difference in the activation energy, obtained in
the two studies, might by explained either by a direct
influence of the high cation concentration on the
transporter or, as it was discussed above, to the
cooperative mechanism by which two or more cations
cooperate to achieve a transport event.
It is questionable whether manganese ions are
transported inside the red blood cells via the calcium
transport systems. It is known that calcium transport
into the red blood cells have mainly two components:
a saturable flux component of about 50 mmolrl
 y11 2 .cell=h i.e. ;10 molrm s , which is reduced
by ATP depletion and has at its turn two components,
selectively inhibited by different Ca2q-channel entry
w xblockers 14 ; a linear flux component, which corre-
sponds to a permeability coefficient of less than
2=10y13 mrs. On the other hand human erythro-
cytes possess a strong ATP consuming Ca pump,
which is able to extrude calcium outside the cells
 y9with a rate of 10–25 mmolrl cell=h i.e.2–5=10
2 . w xmolrm =s 32 .
The manganese influx reported in this paper is
about 2–3 orders of magnitude higher than Ca2q
influx in human erythrocytes. The idea that man-
ganese is transported into the red cells via the same
transporter as calcium is conceivable with this dis-
crepancy if we suppose that the transporter has a 2–3
order of magnitude higher affinity for manganese
than for calcium. It was reported that 1mM Ca a
concentration which is also the half saturation con-
.stant for calcium influx reduces manganese influx
into the red blood cells to 50%, for very low man-
 y5 . w xganese concentrations. 10 M 1 . In other words a
2 order of magnitude higher calcium concentration
can significantly inhibit manganese influx into red
blood cells. On the other hand, at least partially,
calcium influx in human erythrocytes occurs via a
‘calcium channel’, being reduced in the presence of
calcium channels antagonists. It is known that man-
ganese is transported in many excitable cells via the
w xcalcium channels or other calcium transporters 2–12 .
Our results on manganese influx in the presence of
nifedipine support the hypothesis that manganese can
penetrate the red blood cell membranes through
‘calcium channels’.
The increase in the manganese influx for ‘in vitro’
aged erythrocytes, correlated with the same effect
( )C.M. Lucaciu et al.rBiochimica et Biophysica Acta 1328 1997 90–9898
observed in vanadate treated cells, led us to hypothe-
sis that human erythrocytes possess an ATP depen-
dent mechanism by which they can face the man-
ganese ions influx. From this point of view, the
manganese uptake measured without vanadate treat-
ment in fresh erythrocytes is only the balance be-
tween passive manganese influx and active extrusion.
In vanadate treated cells the active extrusion being
blocked, what we measure is only the passive diffu-
sion influx.
One mechanism by which the cells oppose to
manganese influx might be Ca2q-Mg2q ATP. The
difference between the manganese influx in vanadate
treated erythrocytes and fresh cells matches the maxi-
mum pumping rate of the calcium pump. It is known
that manganese can activate the red blood cell AT-
Pases either from the cytosol or from the cell mem-
w x 2qbranes 33,34 and it modulates the Sr transport
w xthrough the calcium pump 35 . At the same time it
was demonstrated that manganese is transported
through the calcium pump of the sarcoplasmic reticu-
w xlum 36 . For other mammalian species it was demon-
strated that manganese is transported into erythrocyte
w xthrough the Na-Ca exchanger 37 , which lacks in
human erythrocytes.
We believe that our results support the idea that
manganese can be transported through the human
erythrocyte calcium pump at least at the concentra-
tions used in our study. However, further experiments
are needed to prove this hypothesis as well as to
extrapolate these findings to physiological concentra-
tions.
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